DK1423126T3 - Behandling af hyperproliferative lidelser på kropsoverflader - Google Patents

Behandling af hyperproliferative lidelser på kropsoverflader

Info

Publication number
DK1423126T3
DK1423126T3 DK02754556T DK02754556T DK1423126T3 DK 1423126 T3 DK1423126 T3 DK 1423126T3 DK 02754556 T DK02754556 T DK 02754556T DK 02754556 T DK02754556 T DK 02754556T DK 1423126 T3 DK1423126 T3 DK 1423126T3
Authority
DK
Denmark
Prior art keywords
treatment
body surfaces
hyperproliferative disorders
psoriasis
relates
Prior art date
Application number
DK02754556T
Other languages
Danish (da)
English (en)
Inventor
Thomas Broe Christensen
Bjarne Bymose
Original Assignee
Valderm Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valderm Aps filed Critical Valderm Aps
Application granted granted Critical
Publication of DK1423126T3 publication Critical patent/DK1423126T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02754556T 2001-08-14 2002-08-12 Behandling af hyperproliferative lidelser på kropsoverflader DK1423126T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101218 2001-08-14
PCT/DK2002/000530 WO2003015759A2 (fr) 2001-08-14 2002-08-12 Traitement d'etats hyperproliferatifs des surfaces corporelles

Publications (1)

Publication Number Publication Date
DK1423126T3 true DK1423126T3 (da) 2008-02-04

Family

ID=8160668

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02754556T DK1423126T3 (da) 2001-08-14 2002-08-12 Behandling af hyperproliferative lidelser på kropsoverflader

Country Status (13)

Country Link
US (2) US7345023B2 (fr)
EP (1) EP1423126B1 (fr)
JP (1) JP4361789B2 (fr)
AT (1) ATE371458T1 (fr)
AU (1) AU2002320964B2 (fr)
CY (1) CY1107814T1 (fr)
DE (1) DE60222144T2 (fr)
DK (1) DK1423126T3 (fr)
ES (1) ES2292789T3 (fr)
NZ (1) NZ531408A (fr)
PT (1) PT1423126E (fr)
SI (1) SI1423126T1 (fr)
WO (1) WO2003015759A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2456423A2 (fr) 2009-07-17 2012-05-30 Valderm APS Traitement de troubles hyperprolifératifs
WO2013026454A1 (fr) 2011-08-22 2013-02-28 Valderm Aps Traitement d'états cliniques avec des anthracyclines
CA2986295C (fr) 2015-07-10 2023-01-03 Infectopharm Arzneimittel Und Consilium Gmbh Utilisation d'hydroxyde de potassium dans le traitement de la keratose actinique
CN108098458B (zh) * 2017-08-09 2019-12-24 徐先顺 一种用于抗hpv6/11的凝胶剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149710A (en) * 1985-04-01 1992-09-22 National Research Development Corporation Pharmaceutical compositions for treating psoriasis
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4946683A (en) * 1987-11-18 1990-08-07 Vestar, Inc. Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
WO1989010122A1 (fr) * 1988-04-27 1989-11-02 Yale University Procedes et compositions de traitement de troubles hyperproliferatifs cutanes
US6231855B1 (en) * 1991-03-12 2001-05-15 Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Monoclonal antibodies as antidotes for anthracycline antibiotics
JP3251735B2 (ja) * 1992-09-25 2002-01-28 株式会社東芝 半導体集積回路装置
US5396195A (en) * 1993-12-13 1995-03-07 At&T Corp. Low-power-dissipation CMOS oscillator circuits
US6190691B1 (en) * 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5900763A (en) * 1994-10-11 1999-05-04 Motorola, Inc. Circuit and method of reducing cross-talk in an integrated circuit substrate
PT751144E (pt) * 1995-06-27 2004-12-31 Pharmachemie Bv Novos pro-farmacos antraciclinicos, metodo para preparacao e tambem a sua utilizacao em quimioterapia selectiva
DE19720312A1 (de) * 1997-05-15 1998-11-19 Hoechst Ag Zubereitung mit erhöhter in vivo Verträglichkeit
US5776915A (en) * 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
AU3764099A (en) 1998-04-28 1999-11-16 Tao Chen Polyanionic polymers which enhance fusogenicity
CA2331620A1 (fr) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Utilisation de neomycine pour le traitement de maladies associees a l'angiogenese
WO2000056267A2 (fr) * 1999-03-19 2000-09-28 Waldemar Priebe Procedes et compositions destines a la fabrication d'antibiotiques du type anthracyclines a substitution en c-3' et c-4'
JP2001345428A (ja) * 2000-03-27 2001-12-14 Toshiba Corp 半導体装置とその製造方法
US6555095B1 (en) * 2001-12-14 2003-04-29 Avon Products, Inc. Topical compositions and methods of application

Also Published As

Publication number Publication date
WO2003015759A3 (fr) 2004-03-04
US20080119546A1 (en) 2008-05-22
US20040242507A1 (en) 2004-12-02
CY1107814T1 (el) 2013-06-19
WO2003015759A2 (fr) 2003-02-27
ATE371458T1 (de) 2007-09-15
PT1423126E (pt) 2007-12-07
SI1423126T1 (sl) 2008-02-29
US7345023B2 (en) 2008-03-18
ES2292789T3 (es) 2008-03-16
AU2002320964B2 (en) 2008-03-13
DE60222144D1 (de) 2007-10-11
DE60222144T2 (de) 2008-05-15
EP1423126A2 (fr) 2004-06-02
US8263567B2 (en) 2012-09-11
NZ531408A (en) 2005-07-29
JP4361789B2 (ja) 2009-11-11
EP1423126B1 (fr) 2007-08-29
JP2005504765A (ja) 2005-02-17

Similar Documents

Publication Publication Date Title
CY1106628T1 (el) Τοπικες φαρμακευτικες συνθεσεις περιλαμβανουσες προανθοκυανιδινες, γλυκυρροχητινικο οξυ και τελμεστεϊνη για τη θεραπεια των δερματιτιδων
WO2003018619A3 (fr) Peptides antimicrobiens et anti-inflammatoires
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
NO20024005D0 (no) Pteridinforbindelser for behandling av psoriasis
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
EE200400005A (et) Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine
CY1107814T1 (el) Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος
DE60229235D1 (de) D kupfersulfaten und sucralphat
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
EA200500326A1 (ru) Применение ферментированного экстракта проростков пшеницы в качестве противовоспалительного агента
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
DOP2002000472A (es) Amidas de acido piperazinciclohexanocarboxilico sustituidas y su utilizacion.
ATE241640T1 (de) Fusidinsäure-derivate
HUP0402624A2 (hu) Vírusgátlás n-dokozanollal
DOP2001000245A (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso.
SE0002045D0 (sv) New use
ES2190373B1 (es) Uso del acido 2-hidroxi- o 2-acetiloxi-4-trifluorometilbenzoico como agente para el tratamiento y prevencion del deterioro cognitivo ligero.
WO2002072527A3 (fr) Derives de l'acide butyrique et leur application
SE9901273D0 (sv) Novel compounds
DOP2003000657A (es) Amidas de acidos 2-heteroarilcarboxilicos